The role of noise and positive feedback in the onset of autosomal dominant diseases

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Bosl, William J ^a,b   Li, Rong ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CHROMOSOME DISORDER; COMPUTER SIMULATION; DISEASE COURSE; DOMINANT GENE; FEEDBACK SYSTEM; GENE REGULATORY NETWORK; HUMAN; KIDNEY POLYCYSTIC DISEASE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS; SYSTEMS BIOLOGY;

CHROMOSOME DISORDERS; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEEDBACK, PHYSIOLOGICAL; GENE REGULATORY NETWORKS; GENES, DOMINANT; HUMANS; MODELS, BIOLOGICAL; POLYCYSTIC KIDNEY DISEASES; STOCHASTIC PROCESSES; SYSTEMS BIOLOGY;

EID: 77953923861     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-93     Document Type: Article

References (48)

1. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001, 1:157-162. 10.1038/35101031, 11905807.
2. Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 1996, 122:135-140. 10.1007/BF01366952, 8601560.
3. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823. 10.1073/pnas.68.4.820, 389051, 5279523.
4. Soto AM, Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm?. Bioessays 2004, 26:1097-1107. 10.1002/bies.20087, 15382143.
5. Sonnenschein C, Soto AM. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. Mol Carcinog 2000, 29:205-211. 10.1002/1098-2744(200012)29:4<205::AID-MC1002>3.0.CO;2-W, 11170258.
6. Veitia RA. Exploring the etiology of haploinsufficiency. Bioessays 2002, 24:175-184. 10.1002/bies.10023, 11835282.
7. Ogino S, Wilson RB, Gold B, Flodman P. Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance. J Genet Couns 2007, 16:29-39. 10.1007/s10897-006-9040-9, 17295057.
8. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N, Alon U. Variability and memory of protein levels in human cells. Nature 2006, 444:643-646. 10.1038/nature05316, 17122776.
9. Abdulkadir SA. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann N Y Acad Sci 2005, 1059:33-40. 10.1196/annals.1339.018, 16382041.
10. Magee JA, Abdulkadir SA, Milbrandt J. Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 2003, 3:273-283. 10.1016/S1535-6108(03)00047-3, 12676585.
11. Kemkemer R, Schrank S, Vogel W, Gruler H, Kaufmann D. Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. Proc Natl Acad Sci USA 2002, 99:13783-13788. 10.1073/pnas.212386999, 129775, 12368469.
12. Cook DL, Gerber AN, Tapscott SJ. Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci USA 1998, 95:15641-15646. 10.1073/pnas.95.26.15641, 28097, 9861023.
13. Karmakar R, Bose I. Stochastic model of transcription factor-regulated gene expression. Phys Biol 2006, 3:200-208. 10.1088/1478-3975/3/3/005, 17021384.
14. Seidman JG, Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J Clin Invest 2002, 109:451-455. 150881, 11854316.
15. Brandman O, Ferrell JE, Li R, Meyer T. Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science 2005, 310:496-498. 10.1126/science.1113834, 16239477.
16. Hornung G, Barkai N. Noise propagation and signaling sensitivity in biological networks: a role for positive feedback. PLoS Comput Biol 2008, 4:e8. 10.1371/journal.pcbi.0040008, 2174979,2174979, 18179281.
17. Buzsáki G. Rhythms of the brain 2006, Oxford; New York: Oxford University Press.
18. Zaks MA, Sailer X, Schimansky-Geier L, Neiman AB. Noise induced complexity: from subthreshold oscillations to spiking in coupled excitable systems. Chaos 2005, 15:26117. 10.1063/1.1886386, 16035919.
19. Gao J. Multiscale analysis of complex time series: integration of chaos and random fractal theory, and beyond 2007, Hoboken, N.J.: Wiley-Interscience.
20. Kantz H, Schreiber T. Nonlinear time series analysis 2004, Cambridge, UK; New York: Cambridge University Press, 2.
21. Raser JM, O'Shea EK. Noise in gene expression: origins, consequences, and control. Science 2005, 309:2010-2013. 10.1126/science.1105891, 1360161, 16179466.
22. Laforge B, Guez D, Martinez M, Kupiec JJ. Modeling embryogenesis and cancer: an approach based on an equilibrium between the autostabilization of stochastic gene expression and the interdependence of cells for proliferation. Prog Biophys Mol Biol 2005, 89:93-120. 10.1016/j.pbiomolbio.2004.11.004, 15826673.
23. Arias AM, Hayward P. Filtering transcriptional noise during development: concepts and mechanisms. Nat Rev Genet 2006, 7:34-44. 10.1038/nrg1750, 16369570.
24. Blake WJ, M KA, Cantor CR, Collins JJ. Noise in eukaryotic gene expression. Nature 2003, 422:633-637. 10.1038/nature01546, 12687005.
25. https://simtk.org/home/bionet
26. Bosl WJ. Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery. BMC Syst Biol 2007, 1:13. 10.1186/1752-0509-1-13, 1839891, 17408503.
27. Gabow PA, Schrier RW. Pathophysiology of adult polycystic kidney disease. Adv Nephrol Necker Hosp 1989, 18:19-32.
28. Anonymous Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell 1995, 81:289-298. Anonymous.
29. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995, 10:151-160. 10.1038/ng0695-151, 7663510.
30. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993, 18:467-472.
31. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272:1339-1342. 10.1126/science.272.5266.1339, 8650545.
32. Vassilev PM, Guo L, Chen XZ, Segal Y, Peng JB, Basora N, Babakhanlou H, Cruger G, Kanazirska M, Ye C, et al. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun 2001, 282:341-350. 10.1006/bbrc.2001.4554, 11264013.
33. Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 2001, 98:1182-1187. 10.1073/pnas.021456598, 14729, 11252306.
34. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H, Kucherlapati R, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998, 93:177-188. 10.1016/S0092-8674(00)81570-6, 9568711.
35. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996, 87:979-987. 10.1016/S0092-8674(00)81793-6, 8978603.
36. Nishio S, Hatano M, Nagata M, Horie S, Koike T, Tokuhisa T, Mochizuki T. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J Clin Invest 2005, 115:910-918. 1059447, 15761494.
37. Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glucksmann-Kuis AM, Schneider MC, Ericsson M, et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996, 98:2674-2682. 10.1172/JCI119090, 507729, 8981910.
38. Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R, Ratcliffe PJ, Gattner K, Harris PC. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 1996, 93:1524-1528. 10.1073/pnas.93.4.1524, 39973, 8643665.
39. Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int 1999, 56:1324-1333. 10.1046/j.1523-1755.1999.00659.x, 10504485.
40. Harris PC, Watson ML. Autosomal dominant polycystic kidney disease: neoplasia in disguise?. Nephrol Dial Transplant 1997, 12:1089-1090. 10.1093/ndt/12.6.1089, 9198029.
41. Li X, Magenheimer BS, Xia S, Johnson T, Wallace DP, Calvet JP, Li R. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 2008, 14:863-868. 10.1038/nm1783, 18552856.
42. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001, 345:971-980. 10.1056/NEJMra002168, 11575290.
43. Greenspan FS, Gardner DG. Basic & clinical endocrinology 2004, New York: McGraw-Hill, 7.
44. Brook CGD, Clayton PE, Brown RS. Brook's clinical pediatric endocrinology 2009, Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell, 6.
45. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997, 17:138-139. 10.1038/ng1097-138, 9326926.
46. Ferrer J. A genetic switch in pancreatic beta-cells: implications for differentiation and haploinsufficiency. Diabetes 2002, 51:2355-2362. 10.2337/diabetes.51.8.2355, 12145145.
47. Bosl WJ, Li R. Mitotic-exit control as an evolved complex system. Cell 2005, 121:325-333. 10.1016/j.cell.2005.04.006, 15882616.
48. Fajans SS, Bell GI. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 2007, 50:2600-2601. 10.1007/s00125-007-0833-7, 17891372.